On Monday, Shares of Cardinal Health Inc (NYSE:CAH), added 1.37% and closed at $72.35 in the last trading session. The last trading range of the stock ranges between $71.16 and $72.81. Cardinal Health (CAH) recently declared that the board of directors approved a regular quarterly dividend of $0.4489 per share, payable Jan. 15, 2017, to shareholders of record on Jan. 3, 2017.
In addition, the company recently released the preliminary results of shareholder voting at its annual meeting of shareholders. Shareholders elected all 11 members of the board of directors standing for election; ratified Ernst & Young as the company’s independent registered public accounting firm; approved the company’s amended long-term incentive plan; and, approved, on a non-binding advisory basis, the compensation of certain executive officers.
Ellie Mae Inc (NYSE:ELLI), dropped -8.62% and closed at $84.93 in the last trading session. The last trading range of the stock ranges between $82.81 and $93.46. The company’s Market capitalization is $2.77 Billion with the total Outstanding Shares of 33.56 million. Refinances by millennial borrowers accounted for 20 percent of all closed loans in September, up from 17 percent of all closed loans in August, according to the most recent Ellie Mae Millennial Tracker™. Eighty percent of millennial loans were purchases, still accounting for the vast majority of closed loans by the demographic. Conversely, the September Ellie Mae Origination Insight Report data showed that 54 percent of closed loans were purchases and 45 percent were refinances.
In Addition To, the time to close loans crept up in September, taking 47 days for all loans to millennial borrowers to close in September, on average, up from 46 days in August. Conventional loans took an average 46 days to close and FHA loans took an average of 47 days. These numbers are aligned with the overall time to close data in the September Origination Insight Report, which showed that the average time to close all loans raised to 48 days in September, up from 46 days in August.
McKesson Corporation (NYSE:MCK), gained 0.46% and closed at $143.69 in the last trading session. The last trading range of the stock ranges between $139.02 and $145.41.Company stock’s 52-week range is $114.53 – $202.20. McKesson Corporation operates as a pharmaceutical distribution services and information technology company in the United States and internationally. It offers pharmaceuticals and medical supplies, and services for healthcare operations. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products; and provides practice administration, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, equipment, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacies in Europe and supports independent pharmacy networks in North America; sells financial, operational, and clinical solutions to pharmacies; and provides consulting, outsourcing, and other services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and planned administration technology solutions; and connectivity, outsourcing, and other services, counting remote hosting and managed services to healthcare organizations. This segments product portfolio addresses various healthcare clinical and business performance needs ranging from medication safety and information access to revenue cycle administration, resource utilization, and physician adoption of electronic health records.